IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v13y2016i3p321-d65775.html
   My bibliography  Save this article

An Evaluation of the Efficacy of Selective Alpha-Blockers in the Treatment of Children with Neurogenic Bladder Dysfunction—Preliminary Findings

Author

Listed:
  • Paweł Kroll

    (Pediatric Surgery and Urology Department, Neurourology Unit, Poznań University of Medical Sciences, ul. Szpitalna 27/33, Poznań 60-572, Poland)

  • Ewa Gajewska

    (Chair for Rheumatology and Rehabilitation, Poznań University of Medical Sciences, ul. 28 Czerwca 135/147, Poznań 61-545, Poland)

  • Jacek Zachwieja

    (Pediatric Nephrology Department, Poznań University of Medical Sciences, ul. Szpitalna 27/33, Poznań 60-572, Poland)

  • Magdalena Sobieska

    (Chair for Rheumatology and Rehabilitation, Poznań University of Medical Sciences, ul. 28 Czerwca 135/147, Poznań 61-545, Poland)

  • Przemysław Mańkowski

    (Pediatric Surgery and Urology Department, Neurourology Unit, Poznań University of Medical Sciences, ul. Szpitalna 27/33, Poznań 60-572, Poland)

Abstract

The aim of this study was to assess the usefulness of selective α1-blockers in children with neurogenic urinary tract dysfunctions and increased leak point pressure (LPP). 14 children from age 6 to 16 years with neurogenic urinary tract dysfunctions (neurogenic bladder) and LPP > 40 cm H 2 O were enrolled in the study. All patients received a selective α1-blocker (doxazosin) for 6–8 weeks with an initial dosage of 0.03 mg/kg. During the observation period the continuation of oral anticholinergics, Clean Intermittent Catheterization (CIC), observation of “urinary dryness” and urinary incontinence periods were recommended. Patients were scheduled for a follow-up visit and urodynamic investigation after 6–8 weeks after the doxazosin therapy was started. In 4 patients, urine leakage occurred at lower pressures; in 9 patients, no significant changes in urine leak point pressures were detected; in 3 patients, there was a significant increase in the bladder capacity; in one patient, deterioration in continence was noted. The differences both in LPP and LPV before and after the treatment were not statistically significant. Our observations are consistent with the conclusions from other studies and showed no evident efficacy of doxazosin in children with neurogenic bladder.

Suggested Citation

  • Paweł Kroll & Ewa Gajewska & Jacek Zachwieja & Magdalena Sobieska & Przemysław Mańkowski, 2016. "An Evaluation of the Efficacy of Selective Alpha-Blockers in the Treatment of Children with Neurogenic Bladder Dysfunction—Preliminary Findings," IJERPH, MDPI, vol. 13(3), pages 1-8, March.
    • Handle: RePEc:gam:jijerp:v:13:y:2016:i:3:p:321-:d:65775
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/13/3/321/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/1660-4601/13/3/321/
    Download Restriction: no
    ---><---

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Monika Miklaszewska & Przemysław Korohoda & Katarzyna Zachwieja & Michał Wolnicki & Małgorzata Mizerska-Wasiak & Dorota Drożdż & Jacek A. Pietrzyk, 2016. "Can We Further Improve the Quality of Nephro-Urological Care in Children with Myelomeningocele?," IJERPH, MDPI, vol. 13(9), pages 1-13, September.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:13:y:2016:i:3:p:321-:d:65775. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.